|
시장보고서
상품코드
2051273
근육내 백신 보조제 시장 : 항원보강제 유형별, 최종사용자별, 용도별, 유통 채널별, 지역별Intramuscular Vaccine Adjuvants Market, By Type of Adjuvants, By End-users, By Applications, By Distribution Channels By Region |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
근육내 백신 보조제 시장은 2026년에 8억 4,540만 달러로 추정되며, 2033년까지 13억 4,860만 달러에 이를 것으로 예상되고 있습니다. 또한 2026-2033년 CAGR 6.9%를 기록할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 8억 4,540만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 6.90% | 2033년 시장 규모 예측 : | 13억 4,860만 달러 |
백신은 감염병을 예방하고 통제하는 가장 효과적인 방법 중 하나로 여겨지고 있습니다. 이는 주로 특정 병원체를 표적으로 삼아 면역 체계를 자극하는 능력에 기인합니다. 또한, 이 제품들은 가격이 저렴하고 여러 질병을 동시에 치료하는 데 사용할 수 있습니다.
시장 역학
세계 근육 내 백신 보조제 시장은 여러 요인으로 인해 예측 기간 동안 상당한 성장을 보일 것으로 예측됩니다. 여기에는 안전하고 효과적인 백신에 대한 수요 증가, 이 분야의 지속적인 혁신 발전, 다양한 민간 및 공공 부문 투자자들의 재정적 지원 등이 포함됩니다. 고령화와 만성질환의 유병률 증가도 세계 백신 보조제 시장의 성장을 가속하는 주요 요인입니다. 또한, 수많은 병원 및 기타 의료시설의 존재는 예측 기간 동안 시장 성장을 가속할 것으로 예측됩니다. 또한, 새로운 치료법의 등장도 시장 성장을 더욱 가속화할 것으로 예측됩니다.
반면, 보조제의 부작용과 독성은 시장 성장을 저해하는 요인으로 작용할 것으로 예측됩니다.
본 조사의 주요 특징
- 이 보고서는 각 부문의 잠재적 수익기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략에 대한 중요한 인사이트를 제공합니다.
- 이 보고서는 다음과 같은 매개변수(기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과, 전략)를 기반으로 세계 근육 내 백신 보조제 시장의 주요 기업 프로파일을 작성했습니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
- 세계 근육 내 백신 보조제 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 근육 내 백신 보조제 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 세계 시장 역학, 규제 및 동향 분석
제4장 세계의 근육내 백신 보조제 시장 : 항원보강제 유형별, 2021년-2033년
제5장 세계의 근육내 백신 보조제 시장 : 최종사용자별, 2021년-2033년
제6장 세계의 근육내 백신 보조제 시장 : 용도별, 2021년-2033년
제7장 세계의 근육내 백신 보조제 시장 : 유통 채널별, 2021년-2033년
제8장 세계의 근육내 백신 보조제 시장 : 지역별, 2021년-2033년
제9장 경쟁 구도
제10장 섹션
LSH 26.06.18Intramuscular Vaccine Adjuvants Market is estimated to be valued at USD 845.4 Mn in 2026 and is expected to reach USD 1,348.6 Mn by 2033, growing at a compound annual growth rate (CAGR) of 6.9% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 845.4 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 6.90% | 2033 Value Projection: | USD 1,348.6 Mn |
Vaccines are considered as one of the most effective methods for the prevention and control of infectious diseases. This is primarily due to their ability to target specific pathogens and stimulate the immune system. Moreover, these products are also inexpensive and can be used to treat multiple diseases simultaneously.
Market Dynamics
The global intramuscular vaccine adjuvants market is expected to experience substantial growth during the forecast period due to several factors. These include an increased demand for safe and effective vaccines, the ongoing pace of innovation in this field, and financial support from various private and public sector investors. A growing geriatric population coupled with increasing prevalence of chronic diseases are other major drivers fuelling growth of the global vaccine adjuvants market. Moreover, the presence of large numbers of hospitals and other healthcare facilities is also expected to propel market growth during the forecast period. In addition, the emergence of novel therapeutics is further expected to boost market growth.
On the other hand, side-effects and toxicity of adjuvants is expected to hinder the market growth.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global intramuscular vaccine adjuvants market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Novavax, Inc., Adjuvance Technologies, Inc., Invivogen, Vaxine Pty Ltd., SEPPIC, SPI Pharma, Inc., Agenus Inc., Avanti Polar Lipids, Inc., CSL Limited, and OZ Biosciences.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global intramuscular vaccine adjuvants market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global intramuscular vaccine adjuvants market.
Market Segmentation
- Global Intramuscular Vaccine Adjuvants Market, By Type of Adjuvants (Revenue, USD Mn, 2021 - 2033)
- Oil-based Adjuvants
- Liposome-based Adjuvants
- Polymer-based Adjuvants
- Mineral-based Adjuvants
- Others
- Global Intramuscular Vaccine Adjuvants Market, By End Users (Revenue, USD Mn, 2021 - 2033)
- Pediatrics
- Adults
- Geriatrics
- Global Intramuscular Vaccine Adjuvants Market, By Applications (Revenue, USD Mn, 2021 - 2033)
- Infectious diseases
- Cancer
- Others
- Global Intramuscular Vaccine Adjuvants Market, By Distribution Channels (Revenue, USD Mn, 2021 - 2033)
- Hospitals
- Clinics
- Research Centers
- Global Intramuscular Vaccine Adjuvants Market, By Region (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Global Intramuscular Vaccine Adjuvants Market Companies
- Novavax, Inc.
- Adjuvance Technologies, Inc.
- Invivogen
- Vaxine Pty Ltd.
- SEPPIC
- SPI Pharma, Inc.
- Agenus Inc.
- Avanti Polar Lipids, Inc.
- CSL Limited
- OZ Biosciences
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Intramuscular Vaccine Adjuvants, By Type of Adjuvants
- Market Intramuscular Vaccine Adjuvants, By End users
- Market Intramuscular Vaccine Adjuvants, By Applications
- Market Intramuscular Vaccine Adjuvants, By Distribution Channels
- Market Intramuscular Vaccine Adjuvants, By Region
- Coherent Opportunity Map (COM)
3. Global Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Growing geriatric population coupled with increasing prevalence of chronic diseases
- Increased government vaccination recommendations
- Restraints
- Side-effects and toxicity of adjuvants
- Opportunities
- Increased research and development activities in this field
- Drivers
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Intramuscular Vaccine Adjuvants Market, By Type of Adjuvants, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Oil-based Adjuvants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Liposome-based Adjuvants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Liposome-based Adjuvants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Mineral-based Adjuvants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
5. Global Intramuscular Vaccine Adjuvants Market, By End Users, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Pediatrics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Adults
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Geriatrics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
6. Global Intramuscular Vaccine Adjuvants Market, By Applications, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Infectious diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
7. Global Intramuscular Vaccine Adjuvants Market, By Distribution Channels, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Research Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
8. Global Intramuscular Vaccine Adjuvants Market, By Region, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, By Country, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Country 2021 - 2033
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Adjuvants, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End Users, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Applications, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channels, 2021 - 2033, (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Adjuvants, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End Users, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Applications, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channels, 2021 - 2033, (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Adjuvants, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End Users, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Applications, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channels, 2021 - 2033, (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Adjuvants, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End Users, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Applications, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channels, 2021 - 2033, (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- South Africa
- North Africa
- Central Africa
9. Competitive Landscape
- Novavax, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Adjuvance Technologies, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Invivogen
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Vaxine Pty Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- SEPPIC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- SPI Pharma, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Agenus Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Avanti Polar Lipids, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- CSL Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- OZ Biosciences
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
10. Section
- Research Methodology
- About us
